Kamran Aryana

502 total citations
63 papers, 332 citations indexed

About

Kamran Aryana is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Kamran Aryana has authored 63 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 25 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Surgery. Recurrent topics in Kamran Aryana's work include Peptidase Inhibition and Analysis (24 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Protease and Inhibitor Mechanisms (13 papers). Kamran Aryana is often cited by papers focused on Peptidase Inhibition and Analysis (24 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Protease and Inhibitor Mechanisms (13 papers). Kamran Aryana collaborates with scholars based in Iran, United States and Austria. Kamran Aryana's co-authors include Ramin Sadeghi, Seyed Rasoul Zakavi, Emran Askari, Giorgio Treglia, Narjess Ayati, Ghasemali Divband, Mohammad Naser Forghani, Vahid Reza Dabbagh Kakhki, Barbara Muoio and Bahram Memar and has published in prestigious journals such as International Journal of Molecular Sciences, European Respiratory Journal and The American Journal of Surgery.

In The Last Decade

Kamran Aryana

51 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamran Aryana Iran 11 153 119 116 86 62 63 332
Yaw Sinn Chin Australia 12 78 0.5× 88 0.7× 89 0.8× 180 2.1× 115 1.9× 26 414
Kyu Chan Lee South Korea 11 110 0.7× 93 0.8× 71 0.6× 128 1.5× 99 1.6× 36 380
Changli Li China 8 90 0.6× 150 1.3× 201 1.7× 43 0.5× 47 0.8× 11 394
Khaled Y. Elbanna Canada 10 90 0.6× 113 0.9× 107 0.9× 68 0.8× 34 0.5× 24 303
Shreya Shah United States 10 72 0.5× 78 0.7× 110 0.9× 188 2.2× 48 0.8× 45 434
Panagiotis Sandilos Greece 10 121 0.8× 62 0.5× 184 1.6× 145 1.7× 63 1.0× 17 391
Baerbel Meteling Australia 7 146 1.0× 109 0.9× 87 0.8× 147 1.7× 22 0.4× 8 353
Eric von Benzon Denmark 9 191 1.2× 47 0.4× 205 1.8× 106 1.2× 11 0.2× 15 414
Jin Young Park South Korea 11 169 1.1× 150 1.3× 145 1.3× 91 1.1× 22 0.4× 44 434
Tian‐Tian Zhai China 13 81 0.5× 152 1.3× 273 2.4× 166 1.9× 17 0.3× 35 486

Countries citing papers authored by Kamran Aryana

Since Specialization
Citations

This map shows the geographic impact of Kamran Aryana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamran Aryana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamran Aryana more than expected).

Fields of papers citing papers by Kamran Aryana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamran Aryana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamran Aryana. The network helps show where Kamran Aryana may publish in the future.

Co-authorship network of co-authors of Kamran Aryana

This figure shows the co-authorship network connecting the top 25 collaborators of Kamran Aryana. A scholar is included among the top collaborators of Kamran Aryana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamran Aryana. Kamran Aryana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aryana, Kamran, et al.. (2025). First Clinical Application of 99mTc-FAPI-46 as an Available Radiotracer to Evaluate the Cardiac Remodeling Process. Clinical Nuclear Medicine. 50(10). e621–e623.
3.
Aryana, Kamran, et al.. (2025). 177Lu-FAPI-2286 Therapy in Metastatic Breast Cancer. Clinical Nuclear Medicine.
4.
5.
Gozashti, Mohammad Hossein, et al.. (2025). 177Lu-FAPI-2286 Therapy in a Patient With Radio-iodine Refractory Papillary Thyroid Carcinoma: A Favorable Clinical and Biochemical Response. Clinical Nuclear Medicine. 50(5). e315–e316. 1 indexed citations
6.
Samadi, Mohammad, et al.. (2025). Remarkable 99mTc-FAPI-46 Uptake in a Patient With Anaplastic Thyroid Carcinoma: A Promising Step in Theranostic Field. Clinical Nuclear Medicine. 50(6). e365–e367.
7.
8.
Askari, Emran, et al.. (2024). [68 Ga]Ga-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression. European Journal of Radiology. 180. 111694–111694. 1 indexed citations
9.
Askari, Emran, et al.. (2024). Quadruplet Therapy in De Novo High-Volume Mixed Neuroendocrine Prostate Cancer Using 177Lu-PSMA. Clinical Nuclear Medicine. 49(3). e120–e122. 1 indexed citations
10.
11.
Aryana, Kamran, et al.. (2024). A Case of Metastatic Pulmonary Calcification Detected on 99mTc-MDP Bone Scan and 99mTc-FAPI Scan. Clinical Nuclear Medicine. 49(9). e441–e443. 2 indexed citations
12.
Samadi, Mohammad, et al.. (2024). Tumor Lysis Syndrome Following PSMA Radioligand Therapy. Clinical Nuclear Medicine. 49(11). e617–e618.
13.
Aryana, Kamran, et al.. (2024). Utilizing 99mTc-FAPI-46 SPECT/CT in Detection of Peritoneal Carcinomatosis in Gastric Poorly Differentiated Adenocarcinoma. Clinical Nuclear Medicine. 50(2). e122–e123. 2 indexed citations
14.
Askari, Emran, et al.. (2022). Could Fibroblast Activation Protein (FAP)‐Specific Radioligands Be Considered as Pan‐Tumor Agents?. Contrast Media & Molecular Imaging. 2022(1). 3948873–3948873. 18 indexed citations
15.
Treglia, Giorgio, et al.. (2021). Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review. International Journal of Molecular Sciences. 22(20). 11192–11192. 35 indexed citations
16.
Ahmadzadehfar, Hojjat, et al.. (2018). The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA. 26(1). 2–8. 15 indexed citations
17.
Kakhki, Vahid Reza Dabbagh, et al.. (2011). Can gallbladder ejection fraction measured by fatty meal cholescitigraphy diagnose chronic cholecystitis. 19(135). 30–39. 1 indexed citations
18.
Sadeghi, Ramin, et al.. (2010). SENSITIVITY OF GALLIUM SCINTIGRAPHY FOR EVALUATION OF RECURRENT LYMPHOMA: COMPARISON OF PLANAR AND SPECT IMAGING. 18(133). 45–51. 5 indexed citations
19.
Jangjoo, Ali, Mohammad Naser Forghani, Vahid Reza Dabbagh Kakhki, et al.. (2009). Minimally invasive radio-guided surgery for hyperparathyroidism: an experience with Tc-99m Sestamibi. 17(1). 12–17. 1 indexed citations
20.
Fard‐Esfahani, Armaghan, et al.. (1998). Localization of ectopic parathyroid adenoma with Tc-99m-MIBI [Persian]. 6(1). 11–17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaw Sinn Chin Breakdown of academic impact, for papers by Kyu Chan Lee Breakdown of academic impact, for papers by Changli Li Breakdown of academic impact, for papers by Khaled Y. Elbanna Breakdown of academic impact, for papers by Shreya Shah Breakdown of academic impact, for papers by Panagiotis Sandilos Breakdown of academic impact, for papers by Baerbel Meteling Breakdown of academic impact, for papers by Eric von Benzon Breakdown of academic impact, for papers by Jin Young Park Breakdown of academic impact, for papers by Tian‐Tian Zhai
Rankless by CCL
2026